Motor and non-motor behaviour in experimental Huntington's disease

Behavioural Brain Research

Volumn 226, Issue 2, 2012, Pages 435-439

  Zeef, Dagmar H ^a,b   Vlamings, Rinske ^a,b   Lim, Lee Wei ^a,b   Tan, Sonny ^a,b   Janssen, Marcus L F ^a,b   Jahanshahi, Ali ^a,b   Hoogland, Govert ^a,b   Prickaerts, Jos ^a,b   Steinbusch, Harry W M ^a,b   Temel, Yasin ^a,b  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b European Graduate School of Neuroscience   (Netherlands)

Author keywords

Anxiety; Food intake; Hedonia; Huntington's disease; Hypermobility; Motivation; Transgenic rats

Indexed keywords

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANXIETY; ARTICLE; CONTROLLED STUDY; CORRELATIONAL STUDY; EMOTION; FOOD INTAKE; HUNTINGTON CHOREA; HYPERKINESIA; LOCOMOTION; MALE; MAZE TEST; MOTIVATION; NONHUMAN; OPEN FIELD TEST; PRIORITY JOURNAL; RAT; SUGAR INTAKE; TRANSGENIC RAT; WILD TYPE;

AGE FACTORS; ANIMALS; ANIMALS, GENETICALLY MODIFIED; ANXIETY; DISEASE MODELS, ANIMAL; EATING; EXPLORATORY BEHAVIOR; HUMANS; HUNTINGTON DISEASE; MALE; MAZE LEARNING; MOTIVATION; RATS;

EID: 81355148484     PISSN: 01664328     EISSN: 18727549     Source Type: Journal    
DOI: 10.1016/j.bbr.2011.09.041     Document Type: Article

References (22)

1. Walker F.O. Huntington's disease. Lancet 2007, 369:218-228.
2. Roos R.A. Huntington's disease: a clinical review. Orphanet J Rare Dis 2010, 5:40.
3. Huntington G. On Chorea. The medical and surgical reporter: a weekly journal 1872, vol. 26. S.W. Butler, Philadelphia, p. 4.
4. Paulsen J.S., Ready R.E., Hamilton J.M., Mega M.S., Cummings J.L. Neuropsychiatric aspects of Huntington's disease. J Neurol Neurosurg Psychiatry 2001, 71:310-314.
5. van Duijn E., Kingma E.M., van der Mast R.C. Psychopathology in verified Huntington's disease gene carriers. J Neuropsychiatry Clin Neurosci 2007, 19:441-448.
6. Craufurd D., Thompson J.C., Snowden J.S. Behavioral changes in Huntington Disease. Neuropsychiatry Neuropsychol Behav Neurol 2001, 14:219-226.
7. Jahanshahi A., Vlamings R., Kaya A.H., Lim L.W., Janssen M.L., Tan S., et al. Hyperdopaminergic status in experimental Huntington disease. J Neuropathol Exp Neurol 2010, 69:910-917.
8. Kantor O., Temel Y., Holzmann C., Raber K., Nguyen H.P., Cao C., et al. Selective striatal neuron loss and alterations in behavior correlate with impaired striatal function in Huntington's disease transgenic rats. Neurobiol Dis 2006, 22:538-547.
9. Reedeker N., Van Der Mast R.C., Giltay E.J., Van Duijn E., Roos R.A. Hypokinesia in Huntington's disease co-occurs with cognitive and global dysfunctioning. Mov Disord 2010, 25:1612-1618.
10. File S.E., Mahal A., Mangiarini L., Bates G.P. Striking changes in anxiety in Huntington's disease transgenic mice. Brain Res 1998, 805:234-240.
11. Cao C., Temel Y., Blokland A., Ozen H., Steinbusch H.W., Vlamings R., et al. Progressive deterioration of reaction time performance and choreiform symptoms in a new Huntington's disease transgenic ratmodel. Behav Brain Res 2006, 170:257-261.
12. Nguyen H.P., Kobbe P., Rahne H., Worpel T., Jager B., Stephan M., et al. Behavioral abnormalities precede neuropathological markers in rats transgenic for Huntington's disease. Hum Mol Genet 2006, 15:3177-3194.
13. von Horsten S., Schmitt I., Nguyen H.P., Holzmann C., Schmidt T., Walther T., et al. Transgenic rat model of Huntington's disease. Hum Mol Genet 2003, 12:617-624.
14. Jahanshahi A., Vlamings R., Kaya A.H., Lim L.W., Janssen M.L., Tan S., et al. Hyperdopaminergic status in experimental Huntington disease. J Neuropathol Exp Neurol 2010, 69:910-917.
15. Lim L.W., Temel Y., Visser-Vandewalle V., Steinbusch H., Schruers K., Hameleers R., et al. Effect of buspirone on the behavioral regulation of rats in low versus high anxiety conditions. Arzneimittelforschung 2008, 58:269-276.
16. Blokland A., Lieben C., Deutz N.E. Anxiogenic and depressive-like effects, but no cognitive deficits, after repeated moderate tryptophan depletion in the rat. J Psychopharmacol 2002, 16:39-49.
17. Shepherd J.K., Grewal S.S., Fletcher A., Bill D.J., Dourish C.T. Behavioural and pharmacological characterisation of the elevated zero-maze as an animal model of anxiety. Psychopharmacology (Berl) 1994, 116:56-64.
18. Prickaerts J., Raaijmakers W., Blokland A. Effects of myocardial infarction and captopril therapy on anxiety-related behaviors in the rat. Physiol Behav 1996, 60:43-50.
19. Jans L.A., Blokland A. Influence of chronic mild stress on the behavioural effects of acute tryptophan depletion induced by a gelatin-based mixture. Behav Pharmacol 2008, 19:706-715.
20. Kubera M., Basta-Kaim A., Papp M. The effect of chronic treatment with imipramine on the immunoreactivity of animals subjected to a chronic mild stress model of depression. Immunopharmacology 1995, 30:225-230.
21. Basar K., Sesia T., Groenewegen H., Steinbusch H.W., Visser-Vandewalle V., Temel Y. Nucleus accumbens and impulsivity. Prog Neurobiol 2010, 92:533-557.
22. Faure A., Hohn S., Von Horsten S., Delatour B., Raber K., Le Blanc P., et al. Altered emotional and motivational processing in the transgenic rat model for Huntington's disease. Neurobiol Learn Mem 2011, 95:92-101.